3-(benzo[d][1,3]dioxol-5-yl)-3-(4-(isoindolin-5-ylamino)-4-oxobutanamido)propanoic acid

ID: ALA1209692

Chembl Id: CHEMBL1209692

PubChem CID: 11975697

Max Phase: Preclinical

Molecular Formula: C22H23N3O6

Molecular Weight: 425.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CC(NC(=O)CCC(=O)Nc1ccc2c(c1)CNC2)c1ccc2c(c1)OCO2

Standard InChI:  InChI=1S/C22H23N3O6/c26-20(24-16-3-1-14-10-23-11-15(14)7-16)5-6-21(27)25-17(9-22(28)29)13-2-4-18-19(8-13)31-12-30-18/h1-4,7-8,17,23H,5-6,9-12H2,(H,24,26)(H,25,27)(H,28,29)

Standard InChI Key:  TYTHBXMTSPUPRQ-UHFFFAOYSA-N

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-3/beta-3 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.44Molecular Weight (Monoisotopic): 425.1587AlogP: 2.07#Rotatable Bonds: 8
Polar Surface Area: 125.99Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.70CX Basic pKa: 8.40CX LogP: -1.59CX LogD: -1.62
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.50

References

1. Krysko AA, Krysko OL, Kabanova TA, Andronati SA, Kabanov VM..  (2010)  Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.,  20  (15): [PMID:20598885] [10.1016/j.bmcl.2010.06.051]

Source